Both in Pharmaceuticals
Structure Therapeutics vs Bicycle Therapeutics
Over the past year GPCR returned −40.0% and BCYC returned −45.1%; their daily moves had a correlation of 0.31.
GPCR −40.0% BCYC −45.1%Growth of $1, one year, split-adjusted
| Metric | GPCR | BCYC |
|---|---|---|
| Price | $20.35 | $3.61 |
| Market cap | $1.45B | $253.0M |
| Today | +6.66% | +3.74% |
| 1 month | −20.7% | −5.2% |
| 6 months | −48.0% | −24.9% |
| Year to date | −70.7% | −49.0% |
| 1 year | −36.8% | −41.5% |
| Revenue growth (YoY) | — | +190.2% |
| Gross margin | — | 100.0% |
| Net margin | — | −30.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 3.0× |
| Net cash | $1.34B | $469.9M |
| Dividend yield | — | — |
| Volatility (60d) | 59.3% | 56.7% |
| Short % of float | — | — |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).